Telomeres and telomerase in cancer
著者
書誌事項
Telomeres and telomerase in cancer
(Cancer drug discovery and development)
Humana , Springer, c2009
- : hbk
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
内容説明・目次
内容説明
Telomerase, an enzyme that maintains telomeres and endows eukaryotic cells with immortality, was first discovered in tetrahymena in 1985. In 1990s, it was proven that this enzyme also plays a key role in the infinite proliferation of human cancer cells. Now telomere and telomerase are widely accepted as important factors involved in cancer biology, and as promising diagnostic tools and therapeutic targets. Recently, role of telomerase in "cancer stem cells" has become another attractive story. Until now, there are several good books on telomere and telomerase focusing on biology in ciliates, yeasts, and mouse or basic sciences in human, providing basic scientists or students with updated knowledge.
目次
Preface Contributors Part I. Basic background 1 Telomeres and Telomerase in Human Keiko Hiyama, Eiso Hiyama, and Jerry W. Shay 2 Telomere Binding Proteins in Human Nadya Dimitrova 3 Regulation of Telomerase through Transcriptional and Post-Translational Mechanisms Amy N. Depcrynski, Patrick C. Sachs, Lynne W. Elmore, and Shawn E. Holt 4 Telomere Dysfunction and the DNA Damage Response Malissa C. Diehl, Lynne W. Elmore, Shawn E. Holt 5 Alternative Lengthening of Telomeres (ALT) in Human Cells Hilda A. Pickett and Roger R. Reddel 6 Mouse model: Telomeres and Telomerase in Stem Cell and Cancer Xin Huang, Zhenyu Ju Part II Telomeres and telomerase in human cancers 7 Role of Telomeres and Telomerase in Cancer Keiko Hiyama, Eiso Hiyama, Keiji Tanimoto, Masahiko Nishiyama 8 Diagnostic Value 1: Solid Tumors Eiso Hiyama and Keiko Hiyama 9 Diagnostic Value 2: Hematopoietic Malignancies Junko H. Ohyashiki and Kazuma Ohyashiki 10 Therapeutic Targets and Drugs 1: Telomerase and Telomerase Inhibitors Brittney-Shea Herbert and Erin M. Goldblatt 11 Therapeutic Targets and Drugs 2: G-quadruplex and G-quadruplex Inhibitors Chandanamali Punchihewa and Danzhou Yang 12 Therapeutic Targets and Drugs 3: Tankyrase 1, Telomere Binding Proteins, and Inhibitors Hiroyuki Seimiya and Takashi Tsuruo 13 Therapeutic Targets and Drugs 4: Telomerase-specific Gene and Vector-based Therapies for Human Cancer Toshiyoshi Fujiwara, Yasuo Urata, and Noriaki Tanaka Part III Experimental protocols 14 Protocol 1: Telomerase Activity and Telomerase Expression Eiso Hiyama 15 Protocol 2: Importance and Methods of Telomere G-tail Length Quantification Akira Shimamoto, Eriko Aoki, Angie M Sera, Hidetoshi Tahara 16 Protocol 3: Detection of Alternative Lengthening of Telomeres (ALT) Wei-Qin Jiang, Jeremy D. Henson, Axel A. Neumann, and Roger R. Reddel Index
「Nielsen BookData」 より